Goldman Sachs’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $4.88M | Buy |
|
|||||
|
2021
Q4 | $4.07M | Buy |
|
|||||
|
2021
Q3 | $1.55M | Buy |
|
|||||
|
2021
Q2 | $1.61M | Buy |
|
|||||
|
2021
Q1 | $1.09M | Sell |
|
|||||
|
2020
Q4 | $3.14M | Sell |
|
|||||
|
2020
Q3 | $2.59M | Buy |
|
|||||
|
2020
Q2 | $2.28M | Buy |
|
|||||
|
2020
Q1 | $1.37M | Sell |
|
|||||
|
2019
Q4 | $5.08M | Buy |
|
|||||
|
2019
Q3 | $1.16M | Buy |
|
|||||
|
2019
Q2 | $562K | Sell |
|
|||||
|
2019
Q1 | $1.02M | Buy |
|
|||||
|
2018
Q4 | $365K | Buy |
|
|||||
|
2018
Q3 | $341K | Sell |
|
|||||
|
2018
Q2 | $277K | Sell |
|
|||||
|
2018
Q1 | $271K | Sell |
|
|||||
|
2017
Q4 | $257K | Sell |
|
|||||
|
2017
Q3 | $1.08M | Sell |
|
|||||
|
2017
Q2 | $1.22M | Sell |
|
|||||
|
2017
Q1 | $1.64M | Buy |
|
|||||
|
2016
Q4 | $307K | Sell |
|
|||||
|
2016
Q3 | $515K | Buy |
|
|||||
|
2016
Q2 | $313K | Buy |
|
|||||
|
2016
Q1 | $20K | Sell |
|
|||||
|
2015
Q4 | $145K | Sell |
|
|||||
|
2015
Q3 | $253K | Buy |
|
|||||
|
2015
Q2 | $147K | Buy |
|
|||||
|
2015
Q1 | $175K | Sell |
|
|||||
|
2014
Q4 | $256K | Buy |
|
|||||
|
2014
Q3 | $175K | Buy |
|
|||||
|
2014
Q2 | $246K | Sell |
|
|||||
|
2014
Q1 | $345K | Sell |
|
|||||
|
2013
Q4 | $586K | Buy |
|
|||||
|
2013
Q3 | $344K | Buy |
|
|||||
|
2013
Q2 | $288K | Buy |
|